Trial intelligence / Profile preview

Hepatitis B Booster in Children Primed with Hexavalent Vaccines

NCT00693186Phase 3Completed

Sponsor
Sanofi
Start
Oct 2008
Primary completion
Dec 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of hepatitis B vaccine (recombinant) in hepatitis B (HBV), sponsored by Sanofi. Started Oct 2008; status: completed.

02

Drugs

hepatitis B vaccine (recombinant)
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT00693186.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00693186.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call